College of Food Science and Engineering, Ocean University of China, Qingdao, 266003, Shangdong, China.
Marine Biomedical Research Institute of Qingdao, Qingdao, 266071, Shandong, China.
Food Funct. 2022 Apr 20;13(8):4748-4756. doi: 10.1039/d1fo04357a.
Holothurin A (HA) and Echinoside A (EA) are the most abundant monomers in sea cucumber saponins, exhibiting different structures only in the side chain at position 20. However, although sea cucumber saponins have been proved to have osteogenic activity, the effect and structure-activity relationship of sea cucumber saponins to improve osteoporosis remain unknown. In the current study, mice with ovariectomization-induced osteoporosis were orally administered with HA and EA for 90 days. The result showed that both HA and EA reduced the levels of serum osteogenesis markers ALP, collagen I, and OCN and bone resorption markers MMP-9, Cath-K and TRAP, and thus inhibited the high bone turnover induced by ovariectomy. Furthermore, we found that HA and EA increased the bone mineral density and apposition rate, reversed the loss of trabecular bone and bone marrow stroma, in which EA exhibited more effective effects. CB1 and MKP-1 are the targets of the glucocorticoid-like effect of saponins. PCR and western blot results indicated that HA and EA alleviated overactive osteogenesis stimulating CB1 and MKP-1, downregulating the PI3K/AKT/β-catenin signal pathway. The OPG/RANKL/NF-κB pathway was identified as a critical regulator of bone resorption. Further investigation revealed that HA and EA significantly downregulate the expression of IKK, NF-κB and phosphorylated NF-κB p65, suppressing the expression of osteoclastogenesis transcription factors c-fos and NFATC1. To the best of our knowledge, this is the first report showing that both HA and EA improved osteoporosis, and these activities depend on the structure of saponins. These findings would provide guidance for the application of saponins in the management of osteoporosis.
海参素 A (HA) 和 Echinoside A (EA) 是海参皂苷中含量最丰富的单体,仅在 20 位侧链结构上有所不同。然而,尽管海参皂苷已被证明具有成骨活性,但海参皂苷改善骨质疏松症的作用和构效关系仍不清楚。在本研究中,通过灌胃给予去卵巢骨质疏松症小鼠 HA 和 EA 90 天。结果表明,HA 和 EA 均降低了血清成骨标志物 ALP、胶原 I 和 OCN 以及破骨标志物 MMP-9、Cath-K 和 TRAP 的水平,从而抑制了去卵巢引起的高骨转换。此外,我们发现 HA 和 EA 增加了骨矿物质密度和附著率,逆转了小梁骨和骨髓基质的丢失,其中 EA 表现出更有效的作用。CB1 和 MKP-1 是皂苷类药物具有糖皮质激素样作用的靶点。PCR 和 Western blot 结果表明,HA 和 EA 通过减轻过度活跃的成骨刺激 CB1 和 MKP-1 来缓解骨质疏松症,下调 PI3K/AKT/β-catenin 信号通路。OPG/RANKL/NF-κB 通路被鉴定为骨吸收的关键调节因子。进一步的研究表明,HA 和 EA 显著下调 IKK、NF-κB 和磷酸化 NF-κB p65 的表达,抑制破骨细胞生成转录因子 c-fos 和 NFATC1 的表达。据我们所知,这是首次报道 HA 和 EA 改善骨质疏松症,这些活性依赖于皂苷的结构。这些发现将为皂苷在骨质疏松症管理中的应用提供指导。